Funding Details
- Awarder
- StartEngine
- Date Award
- June 13, 2024
- Vertical
- Healthcare
- Funding URL
- View Funding Page
- Premoney Valuation
-
$1,000,000
- Valuation
-
$11,050,000
Company Info
- Founding Year
- Not provided in the memo
- Traction
- JelikaLite has completed a Phase I placebo-controlled clinical trial of its prototype, showing statistically significant improvement in children who received the treatment. The company has also received a Breakthrough Device Designation from the FDA for its Cognilum system.
- Organizations Involved
- None
- Founders
- Eugenia Steingold, Katya Sverdlov, Luis DeTaboada
- Company Description
- JelikaLite is focused on developing Cognilum, a medical solution aimed at reducing autism symptoms in children through noninvasive brain stimulation using near-infrared light, EEG sensors, and an AI personalization platform. The company aims to provide a personalized, home-based treatment option for children with autism, addressing the limitations of current therapies and medications.
- Market
- Autism Treatment
- Location
-
New York,
NY,
US
- Coinvestors
- None
Links